Allogene Therapeutics, Inc. SEC filings ALLO
Allogene Therapeutics, Inc. has 585 filings in SEC EDGAR's recent list, going back to Apr 19, 2018. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Aug 12, 2026 | — |
| 424B5 | Prospectus supplement | Jun 22, 2026 | — |
| 424B5 | Prospectus supplement | Apr 15, 2026 | — |
| 424B5 | Prospectus supplement | Apr 13, 2026 | — |
| S-8 | Employee stock plan registration | Mar 12, 2026 | — |
| S-8 | Employee stock plan registration | Mar 13, 2025 | — |
| 424B5 | Prospectus supplement | May 14, 2024 | — |
| S-8 | Employee stock plan registration | Mar 14, 2024 | — |
| S-3 | Shelf registration | Mar 14, 2024 | — |
| 424B5 | Prospectus supplement | Nov 2, 2023 | — |
| S-8 | Employee stock plan registration | Feb 28, 2023 | — |
| S-3ASR | Automatic shelf registration | Nov 2, 2022 | — |
| S-8 | Employee stock plan registration | Feb 23, 2022 | — |
| S-8 | Employee stock plan registration | Feb 25, 2021 | — |
| 424B5 | Prospectus supplement | Jun 3, 2020 | — |
| 424B5 | Prospectus supplement | Jun 1, 2020 | — |
| S-8 | Employee stock plan registration | Feb 27, 2020 | — |
| S-3ASR | Automatic shelf registration | Nov 5, 2019 | — |
| S-8 | Employee stock plan registration | Mar 8, 2019 | — |
| S-8 | Employee stock plan registration | Oct 24, 2018 | — |
| 424B4 | Prospectus | Oct 11, 2018 | — |
| S-1MEF | Form s-1mef | Oct 10, 2018 | — |
| S-1/A | Amended registration statement | Oct 5, 2018 | — |
| S-1/A | Amended registration statement | Oct 2, 2018 | — |
| S-1/A | Amended registration statement | Sep 17, 2018 | — |
| S-1 | Registration statement | Sep 14, 2018 | — |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ALLO (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1737287
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.